For Q3 of the fiscal year ending March 2026, revenue was JPY 36,488 million (YoY +23.2%), operating income was JPY 7,767 million (YoY +37.1%), and net income attributable to owners of parent was JPY 4,811 million (YoY +24.6%), achieving growth in both revenue and profit.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4483","jir_company_name":"JMDC Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-02-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4483-20260205-02.pdf","jir_short_summary":"For Q3 of the fiscal year ending March 2026, revenue was JPY 36,488 million (YoY +23.2%), operating income was JPY 7,767 million (YoY +37.1%), and net income attributable to owners of parent was JPY 4,811 million (YoY +24.6%), achieving growth in both revenue and profit.","jir_summary":"### Overview of Business Results\nDuring the cumulative consolidated period of Q3 for the fiscal year ending March 2026, revenue increased to JPY 36,488 million (YoY +23.2%), operating income rose to JPY 7,767 million (YoY +37.1%), and EBITDA grew to JPY 9,682 million (YoY +27.1%). By segment, the Health Big Data business showed steady performance with revenue of JPY 31,629 million (YoY +26.4%) and segment profit of JPY 8,579 million (YoY +32.1%), while the Telemedicine business also expanded with revenue of JPY 4,858 million (YoY +5.0%) and segment profit of JPY 1,836 million (YoY +5.8%). Following the stock transfer of Noa Medical System Inc., the Pharmacy Support Business has been classified as a discontinued operation, and comparisons with the previous period are based on continuing operations only.\n\n### Financial Position and Cash Flow\nTotal assets increased by JPY 13,163 million from the end of the previous consolidated fiscal year to JPY 156,184 million. Total liabilities rose by JPY 9,218 million to JPY 73,763 million, while total equity increased by JPY 3,945 million to JPY 82,421 million. Cash flow from operating activities resulted in an inflow of JPY 5,598 million, cash flow from investing activities was an outflow of JPY 7,742 million, and cash flow from financing activities recorded an inflow of JPY 206 million, leading to cash and cash equivalents of JPY 30,239 million\u2014down JPY 1,936 million from the end of the previous period. There is no change to the earnings guidance for the full fiscal year ending March 2026.","jir_financial_highlights":"Revenue: JPY 36,488 million (YoY +23.2%)\nOperating Income: JPY 7,767 million (YoY +37.1%)\nProfit Before Tax: JPY 7,311 million (YoY +32.1%)\nQuarterly Profit: JPY 4,820 million (YoY +23.8%)\nNet Income Attributable to Owners of Parent: JPY 4,811 million (YoY +24.6%)\nEBITDA: JPY 9,682 million (YoY +27.1%)\nTotal Assets: JPY 156,184 million (Compared to end of previous fiscal year +JPY 13,163 million)\nTotal Equity: JPY 82,421 million (Compared to end of previous fiscal year +JPY 3,945 million)\nNumber of Shares Outstanding at Period-End: 65,429,808 shares (Compared to end of the previous period +56,000 shares)\nNumber of Treasury Shares at Period-End: 816 shares (Compared to end of the previous period +85 shares)","jir_category":"","jir_hashtags":"#JMDCInc, #FinancialSummary, #financial_summary, #JapaneseStocks","jir_key_figures":"Revenue: JPY 36,488 million (YoY +23.2%)\nOperating Income: JPY 7,767 million (YoY +37.1%)\nNet Income Attributable to Owners of Parent: JPY 4,811 million (YoY +24.6%)","jir_meta_title":"JMDC Inc. Q3 Financial Summary for Fiscal Year Ending March 2026: Revenue JPY 36,488 Million, Operating Income JPY 7,767 Million (YoY Increase)","jir_meta_description":"JMDC Inc.'s Q3 financial summary for fiscal year ending March 2026. Revenue was JPY 36,488 million (YoY +23.2%), operating income JPY 7,767 million (YoY +37.1%), and net income attributable to owners of parent JPY 4,811 million (YoY +24.6%), achieving growth in both revenue and profit. The Health Big Data segment performed strongly.","jir_og_title":"JMDC Inc. Announces Q3 Financial Summary for Fiscal Year 2026","jir_og_description":"Announcing Q3 financial summary for fiscal year ending March 2026. Revenue was JPY 36,488 million and operating income JPY 7,767 million, both increasing year-over-year.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Revenue Trend (Cumulative Q3)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year 2025 Q3 Cumulative\\\",\\\"Fiscal Year 2026 Q3 Cumulative\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue (Million JPY)\\\",\\\"data\\\":[29623,36488],\\\"backgroundColor\\\":\\\"#4e79a7\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Operating Income Trend (Cumulative Q3)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year 2025 Q3 Cumulative\\\",\\\"Fiscal Year 2026 Q3 Cumulative\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income (Million JPY)\\\",\\\"data\\\":[5664,7767],\\\"backgroundColor\\\":\\\"#f28e2b\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"quarterly_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year 2025 Q3 Cumulative\\\",\\\"Fiscal Year 2026 Q3 Cumulative\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Quarterly Profit (Million JPY)\\\",\\\"data\\\":[3862,4811],\\\"backgroundColor\\\":\\\"#e15759\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"ebitda_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"EBITDA Trend (Cumulative Q3)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Fiscal Year 2025 Q3 Cumulative\\\",\\\"Fiscal Year 2026 Q3 Cumulative\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"EBITDA (Million JPY)\\\",\\\"data\\\":[7619,9682],\\\"backgroundColor\\\":\\\"#76b7b2\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown (Cumulative Q3)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Health Big Data\\\",\\\"Telemedicine\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Fiscal Year 2025 Q3 Cumulative (Million JPY)\\\",\\\"data\\\":[25029,4627],\\\"backgroundColor\\\":\\\"#59a14f\\\"},{\\\"label\\\":\\\"Fiscal Year 2026 Q3 Cumulative (Million JPY)\\\",\\\"data\\\":[31629,4858],\\\"backgroundColor\\\":\\\"#edc948\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":8828,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-24645","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n